Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B

doi:10.3748/wjg.v18.i47.6943

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4430)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

392

HTML

3548

Figures (1-4)

264

Tables (1-1)

226

Sum=4430

Dec 21, 2012 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 21, 2012; 18(47): 6943-6950
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6943

Full Size Figure Download Figure

Figure 4 Cumulative rates of hepatitis B e antigen clearance and hepatitis B e antigen seroconversion during the on-treatment period. A: Hepatitis B e antigen (HBeAg) clearance rate; B: HBeAg seroconversion rate.

Citation: Kim SB, Song IH, Kim YM, Noh R, Kang HY, Lee HI, Yang HY, Kim AN, Chae HB, Lee SH, Kim HS, Lee TH, Kang YW, Lee ES, Kim SH, Lee BS, Lee HY. Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B. World J Gastroenterol 2012; 18(47): 6943-6950
URL: https://www.wjgnet.com/1007-9327/full/v18/i47/6943.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i47.6943